Labeling is a critical tool for the safe and effective use of prescription and non-prescription drugs, biologics, and medical devices. The labeling conveys the essential information needed by payers, providers, and patients to make decisions about access, prescription, and use of these products. In an environment of increasingly complex labeling requirements, this conference provides a forum for regulators and industry to update their knowledge of local and global labeling-related policies, and to share processes, tools, and approaches to ensure effective and compliant labeling.
This program has been developed in collaboration with the Regulatory Affairs Community-Labeling Working Group.
Global Labeling Issues and Updates
Pharmacovigilance Risk Assessment
Plain Language Labeling
Patient Medication Information (PMI)
International Strategic Plan
Reach Your Audience
At DIA conferences, medical product developers, regulators, academics, and patient advocates all come together in one place, eager to receive fresh insight and share new information. DIA conferences are the perfect place for you to communicate your key messages to an influential audience, efficiently and cost effectively.
The DIA Global Labeling 2016 conference offers interested companies the opportunity to exhibit with a tabletop display.
We are also excited to offer additional marketing opportunities to reach conference participants, including a preconference eBlast to registered attendees, or email banner ad.
For more than 50 years, DIA (the Drug Information Association) has served as a global forum for all those involved in health care product development and life cycle management to exchange knowledge and collaborate in a neutral setting. DIA is an essential resource that provides opportunities to extend debate and discussion to advance scientific and medical innovation.